Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
Baxter International ( (BAX) ) just unveiled an announcement.
On January 31, 2025, Baxter International Inc. completed the sale of several entities, including Vantive Health LLC and Gambro Renal Products, to a consortium of buyers for approximately $3.71 billion in cash after adjustments. This transaction marks a significant divestment for Baxter, likely impacting its strategic focus and operations, as well as the stakeholders involved, including the transition of Chris Toth from his executive roles.
More about Baxter International
YTD Price Performance: 11.28%
Average Trading Volume: 4,730,978
Technical Sentiment Consensus Rating: Strong Buy
Current Market Cap: $16.62B
Find detailed analytics on BAX stock on TipRanks’ Stock Analysis page.
